$ABUS $ROIV $MRNA $BNTX $PFE Litigation Update ✅ESI filed! 📆Extended other discovery deadlines. 🔜🍿Since cationic molar ratio LNP previously disclosed - fun part starts when counsel receives/searches through Bancel’s emails, texts, etc. #Patent #Infringement #3XDamages

$OCUL - Trading shenanigans anyone? Idk, but it seems a like odd as it comes on the heels of the enthusiastic Jeffries FC and before Saturday data & Monday news… Been in this one for years - time is ripe for #partnership

$ABUS $ROIV $MRNA $BNTX $BMYRT Litigation Update More so now than ever b4, complex cases are won/lost over Electronic Data Discovery (e.g., cell phone records, texts, emails, etc) & related search terms. 🎯 $ENTA just filed Motion to compel $PFE to use their search terms.

$PDSB - Back in on today’s crash. #risky #donttrythisathome

$ABUS $ROIV $PFE $BNTX Litigation Update 💩Atty for Genevant inexplicably filed letter to Court requesting an EARLIER cnf w/Acuitas b/c “he” has vaca 🥶Judge responded by DELAYING conference until August 8! 🤬Ripple effect = more DELAY in Pfizer case. 🔥Bd fires him TODAY?

$CHRS, added more this morning as it hits a 52 wk low. 🥴Impressed with their May deck & it’s below recent Offering Price of $4.25. With Yusimry launch set for July 1st, cautiously optimistic this one may have legs to upside sooner than later.

$ABUS Perhaps, but these are annual grants. OTOH, this is 3rd ESI extension & it’s a given that $MNRA d/n want to be forced to turn over key individuals’ & Moderna/FDA/1498 related text messages, emails, etc., re: LNP cationic lipid molar ratio patent infringement & royalties.

$ABUS $ROIV $MRNA $BNTX $PFE Update Incredulous: Extension of time to file ESI Stip to June 9th Negotiated enough ESI Stips in my day so d/n need #ChatGPT to smell smoke, ie, must be compelling reason for delays.🔥 Conveniently, Arbutus Board just received 55,000 sh Options

$PDSB Sold full position b4 close. Still a strong believer, but sold today because many biotechs generally don’t seem to follow through or retain a move of this size after big up days (e.g, $OCUL). OTOH, this could be another $IMVT and just continue uptrend. 🤷🏼 #biotech

$OCUL 👀

Hard to believe ~three years have passed, but proud to have participated in Moderna’s COVE Clinical study of Covid19. Will feel even better about it if/when Moderna acknowledges the important contribution of the Arbutus (LNP) and Alnylam (lipid) scientists. #ClinicalTrialsDay

$IMVT $ROIV 👀👀 Still own a few shares of Immunovant. Immunovant’s comeback from the #biotech ashes gives me a glimmer of hope that someday Arbutus will rise again.

$ABUS $ROIV $PFE $BNTX Genevant Litigation Update 👏🏻Counsel for Acuitas filed letter to Court. Polite way of saying, “Hey, Judge V, there’s been a MTD pending since Fall of ‘22, care to do your job”? Uncomplicated motion so request for “status conference” is more of a ruse.

$ABUS $ROIV $MRNA $BNTX $PFE Litigation Update Dumbfounded: Extension of time to file ESI Stip to May 26. This is not rocket science. So why protracted delays? Guessing fight may be over historical e-mail & mobile data records, but also solicited #ChatGPT to explain.

$ABUS $ALNY $MRNA $BNTX $PFE Litigation Update Nuggets in Moderna’s counterclaim v Alnylam 🤡Argues 1498 👽Moderna discovered SM-102? - Even if true, cationic lipid is just one component of LNP. Still infringed Arbutus’ patents 🔥Benenato - *former employee - subpoena?

$ALNY $ENTA $MRNA $BNTX $PFE Litigation Update Busy week in some US Federal Courts, but still 🦗 from USDC Judge in Acuitas v $ABUS.

$ENTA Added more at ~$27 in AH. Stock swooning in response to EDP-235 data. However, their 400mg dose may still have legs in terms of competing with $PFE (Paxlovid) and $ABUS AB-343 (down the road). New slide deck is here:

$ABUS $ROIV $MRNA $ALNY Litigation Update Excellent way to end week after FDA hold on AB-101 🤬 💥Judge signed Moderna’s revised PO earlier today, which means no more delay: MRNA must turnover lipid molar ratios. 💥Judge denied Moderna 1498 MTD in Alnylam case

$ABUS $ROIV $MRNA $ALNY $BNTX Litigation Update 💥Protective Order Filed - run-of-the-mill legalese but-for the critically important lipid molar ratios ♟️ALNY told Moderna to pound sand 😂Moderna playing catch up by trying to piggyback on Pfizer

$ABUS $ROIV $MRNA Litigation Update 💥Moderna asked for more time - for a *second* time - until this Wednesday (19th) to file the Protective Order, re: disclosure of Confidential Information ⏳Was due April 11th, then 14th & now 19th. 🧐Not rocket science - something is up

$ROIV $PFE - Huge news! $RXDX being acquired by $MRK for $200 per share in cash or approximately $10.8 billion.

$ABUS $ROIV $PFE $BNTX $MRNA Litigation Update 💥Judge gave Moderna until this Friday (14th) to file Protective Order, re: disclosure of Confidential Information ♟️Arbutus/Genevant filed Reply to Acuitas Response. ☠️‘127 Patent invalidated - was anticipated by ‘069 Patent

$ABUS $ROIV $PFE $BNTX As expected, counsel for Acuitas filed response letter. Up to Judge & time will tell, but think only one side is playing chess. Do respect this quip: “Defendants silently created—and were the sole entrants in—the slowest race to the courthouse ever…”

$ABUS $ROIV $PFE $BNTX Counsel for Genevant sent letter to USDC Judge Vyskocil informing Court of the new USDC case filed in New Jersey against Pfizer & BioNTech. 👉 Strategy revealed in support of MTD 👉 Acuitas - Your move!

$ABUS & Genevant [ $ROIV] sue $PFE & $BNTX for patent infringement seeking a reasonable royalty & that the infringement has been willful & an enhancement of damages. Notes: 👉No mention of Acuitas or DJ case 👉No mention of 2022 NDA 👉Patent ’069 not included- v. $MRNA